noodls browser compatibility check

The security settings of your browser are blocking the execution of scripts.

To use noodls, javascript support must be enabled. Please change your browser's security settings to enable javascript.

If you have changed your browser's security settings, you can click here.

related announcements

News

Ohio House of Representatives

Ohio House Passes Prior Authorization Reform to Reduce Delays and[...]
Illinois Senate Democrats

Senate Democrats display support to end Alzheimer’s
Richard Blumenthal

Blumenthal & Alsobrooks Introduce Bill to Extend WIC Eligibility for[...]

Healthcare

Annovis Bio Inc.

03/25/2026 | Press release | Distributed by Public on 03/25/2026 15:19

Management Change/Compensation (Form 8-K)

Item 5.02.

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements

Effective March 23, 2026, Mark Guerin is no longer employed as as Chief Financial Officer of Annovis Bio, Inc. (the "Company"). Mr. Guerin's departure did not arise from any disagreement with the Company or any matter relating to the Company's operations, policies or practices. The Company anticipates that the board of directors of the Company will appoint Maria Maccecchini, Chief Executive Officer of the Company, to serve as Acting Chief Financial Officer of the Company until a replacement can be identified.

Annovis Bio Inc. published this content on March 25, 2026, and is solely responsible for the information contained herein. Distributed via EDGAR on March 25, 2026 at 21:19 UTC. If you believe the information included in the content is inaccurate or outdated and requires editing or removal, please contact us at [email protected]